Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Unsymmetrical Bisquinolines with High Potency against P. falciparum Malaria

Molecules(2020)10.3390/molecules25092251Source: DataRank Database

Unsymmetrical Bisquinolines with High Potency against P. falciparum Malaria is a research paper published in Molecules (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.06)OA: goldTopics (47)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Steven Burgess ORCID,Bornface Gunsaru,Jane X. Kelly ORCID,Yuexin Li ORCID,Westin Morrill

Live enrichment

PubMed:32397659 PMC:PMC7249153 OpenAlex:https://openalex.org/W3021642737

National Institutes of Health

Grant: AI114806

National Institutes of Health

Grant: 1R41AI072923-01

Designed Antimalarial Agents Overcoming Chloroquine-Resistance

National Institutes of Health

Grant: 5R42AI094959-05

Preclinical development of novel small molecule malaria drugs that overcome drug

National Institutes of Health

Grant: 1R21AI067837-01A2

Reversed Chloroquines as Antimalarial Agents

FWCI

2.06

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1420-3049/25/9/2251/pdf?version=1589109613

publisherhttps://www.mdpi.com/1420-3049/25/9/2251/pdf?version=1589109613

publisherhttps://www.mdpi.com/1420-3049/25/9/2251/pdf

journalhttps://doi.org/10.3390/molecules25092251

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32397659

Fields of Study

Malaria Research and ControlComputational Drug Discovery MethodsPhenothiazines and Benzothiazines Synthesis and Activities0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AntimalarialsChloroquineErythrocytesHumansPlasmodium falciparumQuinolinesStructure-Activity RelationshipMalaria, FalciparumInhibitory Concentration 50

Keywords

ArtemisininPlasmodium falciparumMalariaChloroquineDrugPotencyPharmacologyDrug discoveryAntimalarial AgentIn vitroMedicineBiologyImmunologyBioinformaticsBiochemistryDrug resistanceSARP. FalciparumStructure–activity RelationshipErythrocytesOrganic chemistryArticle<i>P. falciparum</i>AntimalarialsInhibitory Concentration 50Structure-Activity RelationshipQD241-441Malaria -- Prevention -- ResearchMedicine and Health SciencesQuinolinesHumansMalaria, Falciparum

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being